1 receptor is relatively resistant to plasminogen activator inhibitor type Single-chain urokinase-type plasminogen activator bound to its

[1]  B. Schwartz,et al.  Interaction of Single-chain Urokinase and Plasminogen Activator Inhibitor Type 1 (*) , 1995, The Journal of Biological Chemistry.

[2]  J. Henkin,et al.  Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*) , 1995, The Journal of Biological Chemistry.

[3]  J. Potempa,et al.  The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.

[4]  S. Gabbe,et al.  Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. , 1994, The Journal of reproductive medicine.

[5]  S. Gabbe,et al.  Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast. , 1992, American journal of obstetrics and gynecology.

[6]  B. Schwartz,et al.  Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. , 1991, The Journal of biological chemistry.

[7]  K. Danø,et al.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. , 1991, The Journal of biological chemistry.

[8]  K. Danø,et al.  Plasminogen Activation by Receptor-Bound Urokinase , 1991, Seminars in thrombosis and hemostasis.

[9]  S. Gillies,et al.  High level expression of human proteins in murine hybridoma cells: induction by methotrexate in the absence of gene amplification. , 1991, Biochimica et biophysica acta.

[10]  L. Rosenfeld,et al.  Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. , 1990, The Journal of biological chemistry.

[11]  D. Loskutoff,et al.  Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms. , 1988, Biochemistry.

[12]  E. Kruithof,et al.  Plasminogen activator inhibitors--a review. , 1988, Enzyme.

[13]  V. Gurewich,et al.  Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase). , 1987, Blood.

[14]  K. Danø,et al.  Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. , 1986, The Journal of biological chemistry.

[15]  K. Danø,et al.  Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass , 1986, FEBS letters.

[16]  T. Suyama,et al.  Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. , 1985, The Journal of biological chemistry.

[17]  D. Loskutoff,et al.  Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. , 1985, The Journal of biological chemistry.

[18]  E. Kruithof,et al.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. , 1984, Blood.